Results 201 to 210 of about 1,272,790 (293)

Engineering low-symmetry colloidal crystals with optical anisotropies. [PDF]

Sci Adv
Lin H, Lee S, Guo Y, Mkhitaryan V, Solís DM, Martín VF, Taboada JM, Sánchez-Iglesias A, Zhu J, Grzelczak M, Sun L, Lee B, Wang S, Zhou W, Wu J, Van Duyne RP, Obelleiro F, Liz-Marzán LM, García de Abajo FJ, Glotzer SC, Mirkin CA.   +20 more
europepmc   +1 more source

Comparing the Effect of Semi‐Immersive Virtual Reality, Computerized Cognitive Training, and Traditional Rehabilitation on Cognitive Function in Multiple Sclerosis: A Randomized Clinical Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio, Desiree Latella, Lilla Bonanno, Paulo Cezar Rocha dos Santos, Marcos Maldonado‐Díaz, Meir Plotnik, Rosaria De Luca, Angelo Quartarone, Rocco Salvatore Calabrò   +8 more
wiley   +1 more source

Scalable generalized meta-spanners enabling parallel multitasking optical manipulation. [PDF]

Sci Adv
Li T, Gao W, Fu B, Shao T, Fu Y, Zavatski S, Nayak JK, Yan S, Xu X, Wang S, Yao B, Wang Z, Zhu S, Martin OJF, Chan CT.   +14 more
europepmc   +1 more source

OPTICAL INVESTIGATIONS ON EUZNNABIB GLASSES

International Journal of Researches in Biosciences and Agriculture Technology, 2017
openaire   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Exploring the new classes of optical soliton solutions with diverse structure for the (2+1)-dimensional paraxial equation in fiber optics via two analytical methods. [PDF]

Sci Rep
Ibrahim IS, Sabi'u J, Iqbal M, Sulaiman S, Alghabban WG, Gouadria S, Nazar NM.   +6 more
europepmc   +1 more source

Memory and Resting‐State Connectivity in Acute Transient Global Amnesia: A Case–Control fMRI Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Objectives Transient global amnesia (TGA) is a striking model of isolated amnesia. While hippocampal lesions are well described, the network‐level mechanisms and the precise neuropsychological profile remain debated. Our objective was thus to characterize functional and neuropsychological correlates of acute TGA and their ...
Elias El Otmani, Emmanuel Barbeau, Béatrice Lemesle, Emilie Milongo‐Rigal, Sophie Fernandez, Sandrine Charpentier, Jean‐François Albucher, Nicolas Raposo, Fabrice Bonneville, Patrice Péran, Jérémie Pariente   +10 more
wiley   +1 more source

Multi-parametric interferometric reflectance imaging sensor. [PDF]

Sci Rep
Aslan M, Snekvik S, Seymour E, Gür SD, Ergene E, Ünlü NL, Ünlü MS.   +6 more
europepmc   +1 more source

Optical Investigation of Carpet Abrasion

Sen'i Kikai Gakkaishi (Journal of the Textile Machinery Society of Japan), 1985
Toshihiro Gunji, Kagari Hayashi, Tsuneyo Tsuboi   +2 more
openaire   +2 more sources

Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker‐Defined Synucleinopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Isolated rapid eye movement sleep behavior disorder (iRBD) is a prodromal state for Lewy body disorders and exhibits biological heterogeneity that may influence clinical expression and progression. We examined clinical features in individuals with iRBD and biomarker‐defined synucleinopathy.
Daniel Weintraub, Michele K. York, Roseanne Dobkin, Anuprita R. Nair, Ryan Kurth, David‐Erick Lafontant, Chelsea Caspell‐Garcia, Roy N. Alcalay, Ethan G. Brown, Lana M. Chahine, Christopher Coffey, Tatiana Foroud, Douglas Galasko, Karl Kieburtz, Kenneth Marek, Kalpana Merchant, Brit Mollenhauer, Kathleen L. Poston, Andrew Siderowf, Cristina Simonet, Tanya Simuni, Caroline M. Tanner, Thomas F. Tropea, Aleksandar Videnovic, The Parkinson's Progression Markers Initiative   +24 more
wiley   +1 more source